| UniProt ID | ATAD1_HUMAN | |
|---|---|---|
| UniProt AC | Q8NBU5 | |
| Protein Name | ATPase family AAA domain-containing protein 1 | |
| Gene Name | ATAD1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 361 | |
| Subcellular Localization | Peroxisome . Cell junction, synapse, postsynaptic cell membrane . | |
| Protein Description | ATPase that plays a critical role in regulating the surface expression of AMPA receptors (AMPAR), thereby regulating synaptic plasticity and learning and memory. Required for NMDA-stimulated AMPAR internalization and inhibition of GRIA1 and GRIA2 recycling back to the plasma membrane; these activities are ATPase-dependent (By similarity).. | |
| Protein Sequence | MVHAEAFSRPLSRNEVVGLIFRLTIFGAVTYFTIKWMVDAIDPTRKQKVEAQKQAEKLMKQIGVKNVKLSEYEMSIAAHLVDPLNMHVTWSDIAGLDDVITDLKDTVILPIKKKHLFENSRLLQPPKGVLLYGPPGCGKTLIAKATAKEAGCRFINLQPSTLTDKWYGESQKLAAAVFSLAIKLQPSIIFIDEIDSFLRNRSSSDHEATAMMKAQFMSLWDGLDTDHSCQVIVMGATNRPQDLDSAIMRRMPTRFHINQPALKQREAILKLILKNENVDRHVDLLEVAQETDGFSGSDLKEMCRDAALLCVREYVNSTSEESHDEDEIRPVQQQDLHRAIEKMKKSKDAAFQNVLTHVCLD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Ubiquitination | -MVHAEAFSRPLSRN -CCCHHHCCCCCCHH | 4.85 | 27667366 | |
| 8 | Phosphorylation | MVHAEAFSRPLSRNE CCCHHHCCCCCCHHH | 39.78 | 21406692 | |
| 12 | Phosphorylation | EAFSRPLSRNEVVGL HHCCCCCCHHHHHHH | 35.42 | 21406692 | |
| 25 | Ubiquitination | GLIFRLTIFGAVTYF HHHHHHHHHCHHHHH | 3.38 | 32015554 | |
| 29 | Ubiquitination | RLTIFGAVTYFTIKW HHHHHCHHHHHHHHH | 4.57 | 29967540 | |
| 44 | Phosphorylation | MVDAIDPTRKQKVEA HHHCCCCCHHHHHHH | 46.91 | 20068231 | |
| 46 | Ubiquitination | DAIDPTRKQKVEAQK HCCCCCHHHHHHHHH | 57.88 | 22817900 | |
| 53 | "N6,N6-dimethyllysine" | KQKVEAQKQAEKLMK HHHHHHHHHHHHHHH | 59.53 | - | |
| 53 | Methylation | KQKVEAQKQAEKLMK HHHHHHHHHHHHHHH | 59.53 | - | |
| 54 | Ubiquitination | QKVEAQKQAEKLMKQ HHHHHHHHHHHHHHH | 42.55 | 21890473 | |
| 55 | Ubiquitination | KVEAQKQAEKLMKQI HHHHHHHHHHHHHHH | 23.95 | 22817900 | |
| 56 | Ubiquitination | VEAQKQAEKLMKQIG HHHHHHHHHHHHHHC | 44.20 | 22817900 | |
| 60 | Ubiquitination | KQAEKLMKQIGVKNV HHHHHHHHHHCCCCC | 49.56 | 29967540 | |
| 60 | Methylation | KQAEKLMKQIGVKNV HHHHHHHHHHCCCCC | 49.56 | - | |
| 60 | "N6,N6-dimethyllysine" | KQAEKLMKQIGVKNV HHHHHHHHHHCCCCC | 49.56 | - | |
| 65 | Ubiquitination | LMKQIGVKNVKLSEY HHHHHCCCCCCCCHH | 51.30 | 27667366 | |
| 65 | 2-Hydroxyisobutyrylation | LMKQIGVKNVKLSEY HHHHHCCCCCCCCHH | 51.30 | - | |
| 107 | Ubiquitination | ITDLKDTVILPIKKK HHHCCCCEEEEECHH | 6.41 | 22817900 | |
| 112 | 2-Hydroxyisobutyrylation | DTVILPIKKKHLFEN CCEEEEECHHHHHCC | 54.55 | - | |
| 112 (in isoform 1) | Ubiquitination | - | 54.55 | 21890473 | |
| 112 | Ubiquitination | DTVILPIKKKHLFEN CCEEEEECHHHHHCC | 54.55 | 22817900 | |
| 112 (in isoform 2) | Ubiquitination | - | 54.55 | 21890473 | |
| 113 | Ubiquitination | TVILPIKKKHLFENS CEEEEECHHHHHCCC | 46.26 | 22817900 | |
| 114 | Ubiquitination | VILPIKKKHLFENSR EEEEECHHHHHCCCC | 40.30 | 27667366 | |
| 114 | Acetylation | VILPIKKKHLFENSR EEEEECHHHHHCCCC | 40.30 | 19608861 | |
| 127 | Ubiquitination | SRLLQPPKGVLLYGP CCCCCCCCEEEEECC | 69.23 | 29967540 | |
| 132 | Phosphorylation | PPKGVLLYGPPGCGK CCCEEEEECCCCCCH | 24.35 | - | |
| 137 | S-nitrosylation | LLYGPPGCGKTLIAK EEECCCCCCHHHHHH | 6.61 | 21278135 | |
| 137 | S-nitrosocysteine | LLYGPPGCGKTLIAK EEECCCCCCHHHHHH | 6.61 | - | |
| 139 | Ubiquitination | YGPPGCGKTLIAKAT ECCCCCCHHHHHHHH | 44.21 | 29967540 | |
| 144 | Acetylation | CGKTLIAKATAKEAG CCHHHHHHHHHHHHC | 39.00 | 25953088 | |
| 144 | Ubiquitination | CGKTLIAKATAKEAG CCHHHHHHHHHHHHC | 39.00 | 27667366 | |
| 146 | Phosphorylation | KTLIAKATAKEAGCR HHHHHHHHHHHHCCE | 37.24 | 19413330 | |
| 148 | Ubiquitination | LIAKATAKEAGCRFI HHHHHHHHHHCCEEE | 43.68 | 29967540 | |
| 151 | Ubiquitination | KATAKEAGCRFINLQ HHHHHHHCCEEEECC | 12.29 | 33845483 | |
| 155 | Ubiquitination | KEAGCRFINLQPSTL HHHCCEEEECCCCCC | 2.32 | 27667366 | |
| 165 | Ubiquitination | QPSTLTDKWYGESQK CCCCCCCCCCCHHHH | 36.76 | 21906983 | |
| 165 (in isoform 2) | Ubiquitination | - | 36.76 | 21890473 | |
| 165 (in isoform 1) | Ubiquitination | - | 36.76 | 21890473 | |
| 165 | Acetylation | QPSTLTDKWYGESQK CCCCCCCCCCCHHHH | 36.76 | 26051181 | |
| 167 | Phosphorylation | STLTDKWYGESQKLA CCCCCCCCCHHHHHH | 19.43 | 26657352 | |
| 181 | Ubiquitination | AAAVFSLAIKLQPSI HHHHHHHHHHHCCEE | 8.82 | 21963094 | |
| 202 | Phosphorylation | DSFLRNRSSSDHEAT HHHHHCCCCCHHHHH | 37.43 | - | |
| 203 | Phosphorylation | SFLRNRSSSDHEATA HHHHCCCCCHHHHHH | 36.23 | 33259812 | |
| 204 | Phosphorylation | FLRNRSSSDHEATAM HHHCCCCCHHHHHHH | 44.21 | - | |
| 205 | Ubiquitination | LRNRSSSDHEATAMM HHCCCCCHHHHHHHH | 45.66 | 27667366 | |
| 209 | Phosphorylation | SSSDHEATAMMKAQF CCCHHHHHHHHHHHH | 16.46 | - | |
| 212 | Ubiquitination | DHEATAMMKAQFMSL HHHHHHHHHHHHHHH | 2.78 | 21890473 | |
| 216 | Ubiquitination | TAMMKAQFMSLWDGL HHHHHHHHHHHHCCC | 4.25 | 22817900 | |
| 228 | Ubiquitination | DGLDTDHSCQVIVMG CCCCCCCCCEEEEEC | 14.73 | 29967540 | |
| 240 | Ubiquitination | VMGATNRPQDLDSAI EECCCCCCCCHHHHH | 33.82 | 21890473 | |
| 242 | Ubiquitination | GATNRPQDLDSAIMR CCCCCCCCHHHHHHH | 55.94 | 21963094 | |
| 244 | Ubiquitination | TNRPQDLDSAIMRRM CCCCCCHHHHHHHHC | 44.29 | 22817900 | |
| 263 (in isoform 1) | Ubiquitination | - | 49.79 | 21890473 | |
| 263 (in isoform 2) | Ubiquitination | - | 49.79 | 21890473 | |
| 263 | 2-Hydroxyisobutyrylation | HINQPALKQREAILK CCCCHHHHHHHHHHH | 49.79 | - | |
| 263 | Ubiquitination | HINQPALKQREAILK CCCCHHHHHHHHHHH | 49.79 | 27667366 | |
| 270 (in isoform 1) | Ubiquitination | - | 27.63 | 21890473 | |
| 270 (in isoform 2) | Ubiquitination | - | 27.63 | 21890473 | |
| 270 | Ubiquitination | KQREAILKLILKNEN HHHHHHHHHHHHCCC | 27.63 | 21963094 | |
| 274 | Ubiquitination | AILKLILKNENVDRH HHHHHHHHCCCCHHH | 56.04 | 27667366 | |
| 274 | Acetylation | AILKLILKNENVDRH HHHHHHHHCCCCHHH | 56.04 | 19829937 | |
| 274 (in isoform 1) | Ubiquitination | - | 56.04 | 21890473 | |
| 280 | Methylation | LKNENVDRHVDLLEV HHCCCCHHHCHHHHH | 27.70 | - | |
| 292 | Phosphorylation | LEVAQETDGFSGSDL HHHHHHCCCCCHHHH | 56.22 | 33259812 | |
| 300 | Acetylation | GFSGSDLKEMCRDAA CCCHHHHHHHHHHHH | 48.68 | 26051181 | |
| 300 | Ubiquitination | GFSGSDLKEMCRDAA CCCHHHHHHHHHHHH | 48.68 | 21963094 | |
| 303 | Glutathionylation | GSDLKEMCRDAALLC HHHHHHHHHHHHHHH | 3.60 | 22555962 | |
| 314 | Phosphorylation | ALLCVREYVNSTSEE HHHHHHHHHHCCCCC | 8.38 | 29255136 | |
| 317 | Phosphorylation | CVREYVNSTSEESHD HHHHHHHCCCCCCCC | 24.22 | 23401153 | |
| 317 | Ubiquitination | CVREYVNSTSEESHD HHHHHHHCCCCCCCC | 24.22 | 29967540 | |
| 318 | Phosphorylation | VREYVNSTSEESHDE HHHHHHCCCCCCCCC | 34.65 | 29255136 | |
| 319 | Phosphorylation | REYVNSTSEESHDED HHHHHCCCCCCCCCC | 38.91 | 23401153 | |
| 322 | Phosphorylation | VNSTSEESHDEDEIR HHCCCCCCCCCCCCC | 31.99 | 29255136 | |
| 347 | Ubiquitination | IEKMKKSKDAAFQNV HHHHHHCHHHHHHHH | 61.33 | 29967540 | |
| 359 | Glutathionylation | QNVLTHVCLD----- HHHHHHHHCC----- | 2.48 | 22555962 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ATAD1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATAD1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATAD1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GOSR1_HUMAN | GOSR1 | physical | 24843043 | |
| TPM2_HUMAN | TPM2 | physical | 28514442 | |
| ANKS6_HUMAN | ANKS6 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-114, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-146, AND MASSSPECTROMETRY. | |
| Ubiquitylation | |
| Reference | PubMed |
| "The proteomic reactor facilitates the analysis of affinity-purifiedproteins by mass spectrometry: application for identifyingubiquitinated proteins in human cells."; Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M.,Haines D.S., Figeys D.; J. Proteome Res. 6:298-305(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-46, AND MASSSPECTROMETRY. | |